Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University College Dublin | OTHER |
| Connolly Hospital Blanchardstown | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Acute consumption of dietary nitrate (as beetroot juice) has been shown to increase exercise and decrease systemic blood pressure in multiple populations, including COPD. The chronic effect of dietary nitrate in obstructive sleep apnea syndrome (OSAS) has not been reported.
Acute consumption of dietary nitrate (as beetroot juice) has been shown to increase exercise and decrease systemic blood pressure in multiple populations, including COPD. The chronic effect of dietary nitrate in OSAS has not been reported.
The investigators hypothesize that chronic nitrate consumption might increase exercise tolerance, and exhaled NO but decrease blood pressure and have little impact on quality of life and pulmonary function.
This study is a randomized, double-blind placebo-controlled, crossover trial. At baseline, mid-point and endpoint exercise tolerance, pulmonary function, quality of life and ambulatory blood pressure will be assessed in conjunction with demographics and blood draw. After baseline measures, each subject will be randomized to consume nitrate rich beetroot juice for 14 consecutive nights when assessments will be repeated followed by 14 nights of placebo and endpoint assessments or the converse.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Nitrate rich beetroot juice | Experimental | Concentrated, beetroot juice is a rich source of dietary nitrate. |
|
| Nitrate depleted placebo beetroot juice | Placebo Comparator | Placebo beetroot juice is identical to active beetroot juice in every way except nitrate content. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dietary nitrate | Dietary Supplement | 140ml of nitrate rich beetroot juice provides 12.9mmol nitrate and will be consumed on a daily basis during the intervention by the study subjects. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in incremental shuttle walk test distance | Day 1, day 15 and day 29 |
| Measure | Description | Time Frame |
|---|---|---|
| Change in plasma nitrate | Assessed by chemiluminescence | Day 1, day 15 and day 29 |
| Change in ambulatory blood pressure | Day 1, day 15 and day 29 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Liam Cormican, MD | Respiratory & Sleep Diagnostics Department, Connolly Hospital, Dublin 15, Ireland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Respiratory & Sleep Diagnostics Department, Connolly Hospital | Dublin | D15 | Ireland |
Not provided
| ID | Term |
|---|---|
| D029424 | Pulmonary Disease, Chronic Obstructive |
| ID | Term |
|---|---|
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D002908 | Chronic Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Placebo | Dietary Supplement | 140ml of nitrate depleted beetroot juice provides 0.5mmol nitrate and will be consumed on a daily basis during the intervention by the study subjects. |
|
|
| Change in quality of life | Quality of Life will be assessed with the Clinical COPD Questionnaire | Day 1, day 15 and day 29 |
| Change in forced expiratory volume | Assessed by spirometry | Day 1, day 15 and day 29 |
| Change in inflammatory markers | Assessed by C-reactive protein | Day 1, day 15 and day 29 |
| Change in forced vital capacity | Assessed by spirometry | Day 1, day 15 and day 29 |
| Change in plasma nitrate and nitrite | Assessed by chemiluminescence | Day 1, day 15 and day 29 |
| D020969 |
| Disease Attributes |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |